The Role of Long Noncoding RNAs (LncRNAs) in the Pathogenesis of Chemoresistance in Endometrial Cancer: A Molecular Approach and Future Perspective

Abbasi Sh, Rezaei J, Bazi F, Alsadat Mousavi M, Rassouli S, Zamanpour Z, Hosseini E, Noori M, Hamidi MZ. Association between metabolic syndrome and risk of endometrial cancer; a systematic review and meta-analysis. Immunopathol Persa. 2025;11(2): e41724. https://doi.org/10.34172/ipp.2025.41724.

Article  Google Scholar 

Fakour F, Bodaghi N, Hajizadeh Fallah H, Etezadi A. Survey of serum level of high risk human papilloma virus antibodies in patients with cervical cancer and CIN I, II, III in pap smears. 2016.

Vakili-Ojarood M, Naseri A, Shirinzadeh-Dastgiri A, Saberi A, HaghighiKian SM, Rahmani A, et al. Ethical considerations and equipoise in cancer surgery. Indian J Surg Oncol. 2024;15(Suppl 3):363–73.

Article  PubMed  Google Scholar 

Aghaei HN, Azimi P, Shahzadi S, Azhari S, Mohammadi HR, Alizadeh P, et al. Outcome measures of functionality, social interaction, and pain in patients with cervical spondylotic myelopathy: a validation study for the Iranian version of the Copenhagen neck functional disability scale. Asian Spine Journal. 2015;9(6):901.

Article  Google Scholar 

Perrotta AR, Borrelli GM, Martins CO, Kallas EG, Sanabani SS, Griffith LG, et al. The vaginal microbiome as a tool to predict rASRM stage of disease in endometriosis: a pilot study. Reprod Sci. 2020;27:1064–73.

Article  CAS  PubMed  Google Scholar 

López-Urrutia E, Bustamante Montes LP, de Guevara L, Cervantes D, Pérez-Plasencia C, Campos-Parra AD. Crosstalk between long non-coding RNAs, micro-RNAs and mRNAs: deciphering molecular mechanisms of master regulators in cancer. Front Oncol. 2019;9:669.

Article  PubMed  PubMed Central  Google Scholar 

Peng W-X, Koirala P, Mo Y-Y. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Can Res. 2017;77(15):3965–81.

Article  CAS  Google Scholar 

HaghighiKian SM, Shirinzadeh-Dastgiri A, Vakili-Ojarood M, Naseri A, Barahman M, Saberi A, et al. A holistic approach to implementing artificial intelligence in lung cancer. Indian J Surg Oncol. 2024:1–22.

Babadi AJ, Kouti RN, Zeinali M, Lordejani MA, Marandi HJ, Farhadi E. Effect of Cervical Index changes on cervical pain. J Iran Med Council. 2024. https://doi.org/10.18502/jimc.v7i3.15731.

Article  Google Scholar 

Chen L, Dzakah EE, Shan G. Targetable long non-coding RNAs in cancer treatments. Cancer Lett. 2018;418:119–24.

Article  CAS  PubMed  Google Scholar 

Fu D, Shi Y, Liu J-B, Wu T-M, Jia C-Y, Yang H-Q, et al. Targeting long non-coding RNA to therapeutically regulate gene expression in cancer. Mol Therapy-Nucleic Acids. 2020;21:712–24.

Article  CAS  Google Scholar 

Jiang W, Xia J, Xie S, Zou R, Pan S, Wang Z-w, et al. Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs. Drug Resist Updates. 2020;50:100683.

Article  Google Scholar 

Khayat Kashani HR, Alizadeh P, Salimi S, Habtemariam S, Khayatkashani M, Tewari D. Epidemiologic profile and outcome of primary pediatric brain tumors in Iran: retrospective study and literature review. Child’s Nervous Syst. 2022;38:1–8.

Google Scholar 

Guo C, Song W, Sun P, Jin L, Dai H. LncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in endometrial cancer cells. J Biomed Sci. 2015;22(1):1–9.

Article  CAS  Google Scholar 

Fang X, Zhong G, Wang Y, Lin Z, Lin R, Yao T. Low GAS5 expression may predict poor survival and cisplatin resistance in cervical cancer. Cell Death Dis. 2020;11(7):531.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lambrou GI, Hatziagapiou K, Zaravinos A. The non-coding RNA GAS5 and its role in tumor therapy-induced resistance. Int J Mol Sci. 2020;21(20):7633.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Y, Ma J, Cui D, Fei X, Lv Y, Lin J. LncRNA MEG3-210 regulates endometrial stromal cells migration, invasion and apoptosis through p38 MAPK and PKA/SERCA2 signalling via interaction with Galectin-1 in endometriosis. Mol Cell Endocrinol. 2020;513: 110870.

Article  CAS  PubMed  Google Scholar 

Zhang P, Shi B, Zhou M, Jiang H, Zhang H, Pan X, et al. Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer. Cell Death Dis. 2014;5(1):e991-e.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chung L-Y, Tang S-J, Sun G-H, Chou T-Y, Yeh T-S, Yu S-L, et al. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2. Clin Cancer Res. 2012;18(15):4037–47.

Article  CAS  PubMed  Google Scholar 

Lv C, Sun J, Ye Y, Lin Z, Li H, Liu Y, et al. Long noncoding RNA EIF1AX-AS1 promotes endometrial cancer cell apoptosis by affecting EIF1AX mRNA stabilization. Cancer Sci. 2022;113(4):1277–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi F, Wang T, Liu Z, Zhang Y, Wang J, Zhang K, et al. LncRNA miR143HG up-regulates p53 in endometrial carcinoma by sponging miR-125a. Cancer Manage Res. 2019;11:10117–23.

Article  CAS  Google Scholar 

Chen JJ, Liu SX, Chen MZ, Zhao ZY. Has-miR-125a and 125b are induced by treatment with cisplatin in nasopharyngeal carcinoma and inhibit apoptosis in a p53-dependent manner by targeting p53 mRNA. Mol Med Rep. 2015;12(3):3569–74.

Article  CAS  PubMed  Google Scholar 

Lu H, Ju D, Yang G, Zhu L, Yang X, Li J, et al. Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma. EBioMedicine. 2019;40:276–89.

Article  PubMed  Google Scholar 

Zhang X-H, Hu P, Xie Y-Q, Kang Y-J, Li M. Long noncoding RNA HOTAIR promotes endometrial carcinoma cell proliferation by binding to PTEN via the activating phosphatidylinositol 3-kinase/Akt signaling pathway. Mol Cell Biol. 2019;39(23):e00251-e319.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xin W, Gao X, Zhao S, Zhao P, Yu H, Wu Q, et al. LncRNA RP11–395G23. 3 suppresses the endometrial cancer progression via regulating microRNA-205–5p/PTEN axis. Am J Transl Res. 2020;12(8):4422.

CAS  PubMed  PubMed Central  Google Scholar 

Chen Q, Schatz C, Cen Y, Chen X, Haybaeck J, Li B. LncRNA TUG1 promotes the migration and invasion in type I endometrial carcinoma cells by regulating E-N cadherin switch. Taiwan J Obstet Gynecol. 2022;61(5):780–7.

Article  PubMed  Google Scholar 

Ranjbary AG, Saleh GK, Azimi M, Karimian F, Mehrzad J, Zohdi J. Superparamagnetic iron oxide nanoparticles induce apoptosis in HT-29 cells by stimulating oxidative stress and damaging DNA. Biol Trace Elem Res. 2023;201(3):1163–73.

Article  CAS  PubMed  Google Scholar 

Dong P, Wang F, Taheri M, Xiong Y, Ihira K, Kobayashi N, et al. Long non-coding RNA TMPO-AS1 promotes GLUT1-mediated glycolysis and paclitaxel resistance in endometrial cancer cells by interacting with miR-140 and miR-143. Front Oncol. 2022;12: 912935.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen J, Yuan Z, Sheng J, Feng X, Wang H, Wang Y, et al. Long non-coding RNA NNT-AS1 positively regulates NPM1 expression to affect the proliferation of estrogen-mediated endometrial carcinoma by interacting. J Cancer. 2022;13(1):112.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeng D, Xiao Y, Zhu J, Peng C, Liang W, Lin H. Knockdown of nucleophosmin 1 suppresses proliferation of triple-negative breast cancer cells through activating CDH1/Skp2/p27kip1 pathway. Cancer Manag Res. 2018;11:143–56. https://doi.org/10.2147/CMAR.S191176.

Article  PubMed  PubMed Central  Google Scholar 

Xing Y, Sun X, Li F, Jiang X, Jiang A, Li X, et al. Long non-coding RNA (lncRNA) HOXB-AS3 promotes cell proliferation and inhibits apoptosis by regulating ADAM9 expression through targeting miR-498-5p in endometrial carcinoma. J Int Med Res. 2021;49(6):03000605211013548.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu R, Gu J, Jiang P, Zheng Y, Liu X, Jiang X, et al. DNMT1–MicroRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9–EGFR–AKT signaling. Clin Cancer Res. 2015;21(4):854–63.

Article 

留言 (0)

沒有登入
gif